a2xfd4d | Knowledge4COVID-19

Property	Value
?:abstract	For survival analysis in comparative coronavirus disease 2019 trials, the routinely used hazard ratio may not provide a meaningful summary of the treatment effect. The mean survival time difference/ratio is an intuitive, assumption-free alternative. However, for short-term studies, landmark mortality rate differences/ratios are more clinically relevant and should be formally analyzed and reported.
?:creator	<https://research.tib.eu/covid-19/entity/McCaw%2C_Zachary_R%3B_Tian%2C_Lu%3B_Kim%2C_Dae_Hyun%3B_Localio%2C_A_Russell%3B_Wei%2C_Lee-Jen>
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/cid/ciaa1563>
?:doi	10.1093/cid/ciaa1563
?:journal	Clin_Infect_Dis
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/8f9b15a41d5b794ca4bb4576c27c7169b2a518c1.json
?:pmc_json_files	document_parses/pmc_json/PMC7665361.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7665361>
?:pmid	<https://research.tib.eu/covid-19/entity/33053155.0>
?:pmid	33053155.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/8f9b15a41d5b794ca4bb4576c27c7169b2a518c1>
?:source	Medline; PMC
?:title	Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-14

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/4a2xfd4d>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/4a2xfd4d>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all